![Erich Bam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erich Bam
Director de Operaciones en ViRexx Medical Corp. .
Perfil
Erich Bam is currently the Chief Operating Officer at ViRexx Medical Corp.
He has a graduate degree from the University of South Africa and an undergraduate degree from the University of Stellenbosch.
Cargos activos de Erich Bam
Empresas | Cargo | Inicio |
---|---|---|
ViRexx Medical Corp.
![]() ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Director de Operaciones | 12/10/2007 |
Formación de Erich Bam.
University of Stellenbosch | Undergraduate Degree |
University of South Africa | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
ViRexx Medical Corp.
![]() ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Erich Bam